Calls
1
Theresa Tse
Chairwoman, Sino Biopharmaceutical
Win Rate
0.0%
return
-23.1%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 14
$7.11
-23.1%
Sino Biopharma has transformed from generics to one of China’s leading innovative pharma companies with strong oncology and chronic disease positions; recent acquisitions of Inova and Hai Jia add 20+ innovative programs in cardiovascular and weight loss, and abundant cash supports continued M&A and R&D.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Theresa Tse has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: CHINA BIOTECH, 1177.HK.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
